Facebook
Twitter
LinkedIn
ForwardCentral Nervous System - Refresher 2022
The course reviews the current clinical management of the most common malignant and benign adult CNS tumors. This review is be followed by an overview of the current clinical practice in the treatment of brain metastases. The speaker reviews the evolving role of stereotactic radiosurgery and whole brain radiotherapy in combination with novel therapeutic agents in the treatment of brain metastases. The presenter discusses in depth the roles of surgery, radiotherapy, and chemotherapy in the management of each of these tumors.
Significant recent progress has been made in the management of CNS tumors, with an emphasis on new molecular prognostic and predictive biomarkers that allow for appropriate treatment selection. Recent updates of the 5th edition WHO Classification of CNS tumors in 2021 include new tumor types that will be summarized. The importance of neuroimaging in helping clinicians improve diagnosis, treatment and response assessment for CNS tumors will be emphasized. This session highlights the need for a multi-disciplinary treatment approach in the management of CNS tumors.
This activity is available from May 9, 2022, through 11:59 p.m. Eastern time on May 8, 2025.
This activity was originally presented and recorded at the 2022 ASTRO Annual Refresher Course.
Target Audience
The activity is designed to meet the interests of radiation oncologists and radiation oncology residents, medical oncologists, surgeons, physicists, nurses, radiation therapists, patologists, radiation therapists and dosimetrists.
Learning Objectives
Upon completion of this activity, participants should be able to do the following:
- Discuss the role of each modality including surgery, radiotherapy, and chemotherapy in managing the major malignant and benign adult primary CNS tumors.
- Describe the new updates of the 5th edition of the WHO Classification of Tumors of the CNS 2021 substantial heterogeneity that exists within these tumor types and understand the prognostic and predictive variables that allow for the selection of the appropriate therapy.
- Discuss key imaging modalities and features to differentiate recurrent tumor and treatment effect.
Christina Tsien, MD is employed by Johns Hopkins University and receives compensation from Varian, Merck, BlueEarth, Novocure and Tocagen.
The person(s) above served as the developer(s) of this activity. Additionally, the ASTRO Education and CME/MOC Committees had control over the content of this activity.
All relevant financial relationships have been mitigated.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
Available Credit
- 1.50 Certificate of AttendanceThis activity was designated for 1.50 AMA PRA Category 1 Credit™.
- 1.50 SA-CME
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.
The American Society for Radiation Oncology (ASTRO) designates this for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.50 self-assessment credits.
Price
Course Fees:
ASTRO members must log in to the ASTRO website to view and receive the discounted member rate.
- Nonmember: $105
- Member: $55
If you are an ASTRO member from a low or lower-middle income country, as identified by the World Bank, you can receive a 50% discount off your corresponding registration for this activity. Please email [email protected] to inquire about the discount.
Policies:
No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the activity by the expiration date.
Participants using ASTRO Academy activities to satisfy the requirement of a Continuing Certification (MOC) program should verify the credit number and type and availability dates of any activity before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased activities that do not align with their MOC requirement.
The activity and its materials will only be available on the ASTRO website until May 8, 2025, regardless of purchase date. At the expiration of the activity, participants will no longer have access to the activity or its materials. ASTRO reserves the right to remove an activity before its expiration date.
Required Hardware/software
One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.